The tumor hypoxia directed nanoparticle used in conjunction with the FDA-approved renal cell carcinoma treatment, Sorafenib had positive outcomes in animal trials.
from Medindia Health News https://ift.tt/2pypbwY
Sunday, 23 September 2018
New Nanoplatform Technology Offers Hope in Treating Drug-resistant Renal Cell Carcinoma
The tumor hypoxia directed nanoparticle used in conjunction with the FDA-approved renal cell carcinoma treatment, Sorafenib had positive outcomes in animal trials.
from Medindia Health News https://ift.tt/2pypbwY
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment